InVivo Enters Commercialization Phase, Adds John A. McCarthy to Board of Directors

Published: Apr 23, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that John A. McCarthy, Chief Executive Officer at CryoXtract, has joined InVivo’s Board of Directors. McCarthy has also been appointed as Chair of the Board’s Audit committee, and has become a member of the Governance, Nominating and Compensation committee.

Help employers find you! Check out all the jobs and post your resume.

Back to news